Nicotine Dependence, Cigarettes
23
3
3
13
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
4.3%
1 terminated out of 23 trials
92.9%
+6.4% vs benchmark
0%
0 trials in Phase 3/4
46%
6 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (23)
The INITIATE Study: Initiating Nicotine Dependence Treatment for Smokers Admitted to Emergency Departments
Neurobehavioral Mechanisms Linking Childhood Adversity to Increased Risk for Smoking
Effects of Nicotine Dependence on Multidimensional Health Outcomes
AI-Enhanced App-based Intervention for Adolescent E-cigarette Cessation
Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients
Re-Connect Application for Smoking Cessation
Helping Poor Smokers Quit
Epidemiology and Acute Oral Effects Electronic Cigarette
Acute Oral Effects of Heated Tobacco Products
The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products
Cigarette Harm Reduction With Electronic Cigarette Use
Impact of Nicotine Messaging on Nicotine Beliefs and Tobacco Use Behavior
Translational Neuropsychopharmacology Research of Nicotine Addiction
Reducing Nicotine Addiction in Adolescent Smokers
Negotiating a Quit Date or Not in Online Interventions
Online Lapse Management Intervention
Comparing the Pharmacokinetics of Nicotine Salt Based ENDS in Healthy Smokers
United States Pre-Market Tobacco Application Pharmacokinetics
Clinical Study Comparing 7 ENDS Products and 1 Combustible Cigarette Using 2 Delivery Methods.
Evaluation of LLLT/Music for Smoking Cessation